Miromatrix Medical Opens New Headquarters and R&D Facility

Miromatrix Medical Inc., a biotechnology company engaged in the development of fully biological human organs to solve the chronic shortage of transplantable organs, utilizing its patented perfusion decellularization/recellularization technology, as well as organ-derived biological products for soft tissue reinforcement and advanced wound care,opened the doors to its new 12,000 square foot headquarters and R&D facility in Eden Prairie, MN.  With the acquisition of this new facility, the company’s Product Development, Sales & Marketing, Finance, and Clinical departments now all sit under one roof. 

In addition to serving as the company’s headquarters, the facility will be the center of Miromatrix’ efforts to create fully biological and transplantable organs.  The facility features a 2,000 square foot cleanroom suite, dedicated lab space for specific organs and bioreactors, custom deionized water system, various incubators, and a number of laminar flow hoods.